Business
BioSpectrum Asia
Victor Ambros and Gary Ruvkun win 2024 Nobel Prize in Physiology or Medicine for discovery of microRNA
The Nobel Assembly at Karolinska Institutet has decided to award the 2024 Nobel Prize in Physiology or Medicine jointly to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Nobel Prize in Chemistry 2024 to trio for cracking code for protein structures
The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2024, with one half to David Baker, University of Washington, US for computational protein design; and the other half jointly to Demis Hassabis, Google DeepMind, London, UK; and John M. Jumper, Google DeepMind, London, UK for protein structure prediction.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
University of Hong Kong to establish Global Innovation Centre
To consolidate Hong Kong's leading position in basic research, the University of Hong Kong (HKU) is planning to establish the Global Innovation Centre (GIC), an upstream technology research facility, in Pokfulam.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
National University of Singapore and Imperial College London establish major research partnership
National University of Singapore (NUS) and Imperial College London have announced a new partnership to strengthen research collaborations.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Managing Delicate Role of Donors for Drug Development and Research
A sustainable, active, and diverse donor pool is more important than ever as the frontiers of medical research continue to push the envelope.
5 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
"The Vietnam Institute is set to play a key role in fostering regional collaborations as a hub for knowledge exchange & partnerships"
The University of Sydney Vietnam Institute, officially launched in June 2024, aims to enhance Vietnam’s scientific capacity and contribute to the country’s economic and social development.
5 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
"Australia is a great place to do business as we have a superb research community, great partners and very experienced clinical trial units"
Noxopharm Limited, an Australian biotech company, is making strides in the fight against cancer and inflammation with its innovative technology platforms, Chroma and Sofra.
5 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
"Moving forward, cancer may not be a death threat but a manageable disease with strong control"
Cartherics Pty Ltd, a Melbourne-based biotechnology company led by renowned stem cell biologist and IVF pioneer Prof Alan Trounson, is , focusing on a portfolio of CAR-T and CAR-NK cell products.
4 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
"To achieve our 'Skilled India' vision, we'll train a large number of individuals quickly and to high standards"
Jayant Singh Chaudhary, Union Minister of State (Independent Charge), Skill Development and Entrepreneurship, Government of India, in an interaction with BioSpecturm in Hyderabad, shares his insights on the various initiatives taken up by the Centre for skill development programmes, boosting self-employment.
5 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Targeted Transformation of Diabetes Care in India
According to the International Diabetes Federation (IDF) about 63 per cent of people with diabetes say that the fear of developing diabetes-related complications affects their well-being.
5 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Digital Innovations in Diabetes Care
Diabetes affects 537 million people globally and is a major contributor to the non-communicable disease NCD) epidemic. Technological tools such as continuous glucose monitors CGMs) and mobile apps are redefining diabetes management. On this World Diabetes Day November 14, 2024), we explore how digital health is transforming diabetes care and the challenges associated with its integration into healthcare systems.
5 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
APAC Bullish on Biosupplier Revenue by Jan Amidst Global Uncertainty
The Asia-Pacific (APAC) market plays a crucial role for global biosupplier companies, contributing anywhere from 15 per cent to 25 per cent of their total global revenues.
10+ min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
WHO adds HPV vaccine for single-dose use
The World Health Organisation (WHO) has announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin (developed by Xiamen Innovax Biotech) has been confirmed for use in a single-dose schedule.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
WHO and multilateral development banks kick off $1.5 B primary health financing platform
Execution is starting under the new Health Impact Investment Platform on the first country health investment plans turning original commitment into operational reality.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Mediwhale secures $12 M to enhance cardiovascular and metabolic disease management
Mediwhale, an artificial intelligence (AI)-powered health diagnostics startup based in South Korea, has announced $12 million series A2 investment.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Singapore launches accelerator programme for startups in digital health innovation
The National University of Singapore (NUS) Medicine Digital Advanced Technology Accelerator (DATA) has launched its Digital Accelerator Programme for startups in the field of digital health innovation.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Alpha Fusion accelerates astatine-based drug discovery with Series B funding
Alpha Fusion, Inc., working on research outcomes from Osaka University and the Japan Science and Technology Agency (JST) OPERA QISS programme, has raised a total of ¥1.02 billion through a Series B funding round.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
India-Australia partnership to build bio innovation corridor
La Trobe University, Australia and India's Biotechnology Industry Research Assistance Council (BIRAC) have signed a Letter of Intent (LOI) to establish a Bio Innovation Corridor to support the development of research and innovation.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Taiwan's Pharmosa Biopharm expands collaboration with Liquida
Liquidia Corporation, a US-based biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, and Taiwan-based Pharmosa Biopharm have amended the current exclusive licensing agreement for the development and commercialisation of L606, an inhaled, sustained-release formulation of treprostinil currently being evaluated in a clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Sunway Healthcare Group inks MoU with Medtronic to advance medical care in Malaysia
Sunway Healthcare Group from Malaysia and Medtronic have officially signed a Memorandum of Understanding (MoU), marking a significant milestone in their collaborative journey to advance medical care, and underscoring a shared vision of developing solutions to tackle some of the most pressing healthcare challenges.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Sanyou Bio opens new 10,000-sqm R&D facility in Shanghai
Sanyou Bio recently announced a move into its new 10,000-square-metre R&D building at Shanghai headquarters.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Cytiva opens first Innovation Hub in Korea
Cytiva, a global life sciences leader, has opened its first Innovation Hub in Korea, located in the Songdo Bio-cluster in Incheon.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Caliway Biopharma raises $206 M in Taiwan's biotech largest IPO
Caliway Biopharmaceuticals has announced the successful completion of its initial public offering (IPO) and up-listing from the Emerging Stock Market to the Taipei Exchange.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
SK bioscience invests $3 M in US-based FinaBio specialising in next-gen conjugate vaccine technology
South Korea-based SK bioscience has signed an agreement to acquire a stake in Fina Biosolutions, based in the US, by investing $3 million.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
China's CanSino receives over $17 M to accelerate polio vaccine development
China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to propel its recombinant poliovirus vaccine (VLP-Polio) project forward.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Japan's Astellas and UK-based AviadoBio ink billion dollar deal for gene therapy targeting frontotemporal dementia
UK-based AviadoBio and Japan's Astellas Pharma Inc. have announced an exclusive option and licence agreement for AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development for patients with frontotemporal dementia with progranulin mutations (FTD-GRN).
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Singapore seizes opportunity to transform healthcare through technology
In response to the convergence of three major developments, namely genomics, artificial intelligence (AI) and the focus on preventive care, the Ministry of Health (MOH) in Singapore is seizing the opportunity to transform healthcare through technology.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
India's CDSCO becomes Affiliate Member of International Medical Device Regulators Forum
To achieve global alignment in its medical device regulatory system, enhance the competitiveness of the domestic industry, and boost transnational prominence, the Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health and Family Welfare, government of India, applied for Affiliate Membership in the International Medical Device Regulators Forum (IMDRF) in 2024.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Greater Bay Area International Clinical Trial Institute in Hong Kong to initiate full operations in 2024
The Health Bureau (HHB), Hong Kong government, has announced that after months of preparation with full effort since the Chief Executive put forward in the Policy
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
New Zealand introduces new Mental Health Bill
The Health Ministry in New Zealand has announced that a new Mental Health Bill has been introduced and is now publicly available.
1 min |